<SEC-DOCUMENT>0001213900-21-021819-index.html : 20210416
<SEC-HEADER>0001213900-21-021819.hdr.sgml : 20210416
<ACCEPTANCE-DATETIME>20210416061919
ACCESSION NUMBER:		0001213900-21-021819
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210416
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210416
DATE AS OF CHANGE:		20210416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GX Acquisition Corp.
		CENTRAL INDEX KEY:			0001752828
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831702591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38914
		FILM NUMBER:		21830058

	BUSINESS ADDRESS:	
		STREET 1:		1325 AVENUE OF THE AMERICAS
		STREET 2:		25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2126163700

	MAIL ADDRESS:	
		STREET 1:		1325 AVENUE OF THE AMERICAS
		STREET 2:		25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea139580-8k_gxacqcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea139580-8k_gxacqcorp.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea139580ex99-1_gxacqcorp.htm
<DESCRIPTION>PRESS RELEASE OF GX ACQUISITION CORP., DATED APRIL 16, 2021
<TEXT>
Document 2 - file: ea139580ex99-1_gxacqcorp.htm

</DOCUMENT>
</SEC-DOCUMENT>